miR‑145 inhibits human non‑small-cell lung cancer growth by dual-targeting RIOK2 and NOB1

International Journal of Oncology
Kun LiuMing-Ming Gu

Abstract

Non-small cell lung cancer (NSCLC) is a leading cause of cancer-associated mortality worldwide. Right open reading frame kinase 2 (RIOK2) and nin one binding protein (NOB1) are important accessory factors in ribosome assembly. In our previous study, RIOK2 and NOB1 were revealed to be highly expressed in NSCLC, and were associated with the clinicopathological characteristics of patients with NSCLC, i.e. TNM clinical stage, lymph node metastasis and differentiation. In addition, RIOK2 expression was correlated with NOB1. To further explore the mechanism and the RIOK2 and NOB1 signaling pathway, microRNA (miR) regulation was analyzed. The tumor suppressor miR‑145 has been reported to be lowly expressed in numerous types of human cancer; in the present study, the expression levels of miR‑145 were decreased in patients with NSCLC. Furthermore, RIOK2 and NOB1 were predicted to be the direct targets of miR‑145 using bioinformatics software; this was further validated using a dual luciferase reporter assay. In addition, the protein expression levels of RIOK2 and NOB1 were inhibited in response to miR‑145 overexpression, thus resulting in the suppression of cell viability, migration and invasion. These results suggested that RIOK2 and N...Continue Reading

References

Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Sep 17, 2004·Nature·Victor Ambros
Sep 21, 2005·Molecular Biology Reports·Yue ZhangShouyuan Zhao
Nov 30, 2005·Nucleic Acids Research·Caifu ChenKarl J Guegler
Aug 27, 2009·Proceedings of the National Academy of Sciences of the United States of America·Allison C Lamanna, Katrin Karbstein
Dec 17, 2009·Cancer Metastasis Reviews·Sylvia K Shenouda, Suresh K Alahari
Nov 16, 2010·The Journal of Biological Chemistry·Heather A WoollsKatrin Karbstein
Feb 2, 2011·PloS One·Melody G Campbell, Katrin Karbstein
Oct 30, 2012·Nature Structural & Molecular Biology·Sébastien Ferreira-CercaNicole LaRonde-LeBlanc
May 21, 2013·The Journal of International Medical Research·Shan LinGuang Chen
Nov 26, 2013·Pathology Oncology Research : POR·Kun LiuQing-Sheng You
Feb 5, 2014·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·G LiuY Sun
Jul 26, 2014·Science·Jennifer C Darnell
Oct 9, 2014·Nucleic Acids Research·Tomasz W TurowskiDavid Tollervey
Dec 3, 2014·The International Journal of Biological Markers·Kun LiuQing-Sheng You
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
May 18, 2016·Translational Lung Cancer Research·Junaid AnsariHazem El-Osta
May 11, 2017·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Cheng En HuGuang Jian Huang
May 14, 2017·EBioMedicine·Florian WeinbergTilman Brummer
May 24, 2017·The Journal of International Medical Research·Hu WeiJiao Jun-Bo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.